Novo Nordisk Faces Pricing Pressure Amid Strong Demand and Competition from Eli Lilly
Novo Nordisk's new weight-loss pill is seeing strong early demand but faces pricing pressure due to competition with Eli Lilly. The company will report Q1 earnings amid concerns about market share retention in the obesity drug sector.
Topics: Eli Lilly Foundayo market competition Novo Nordisk pricing pressure Wegovy